Literature DB >> 24525999

When is chemotherapy in head and neck squamous cell carcinoma not indicated?

Missak Haigentz1, Jan B Vermorken2, Arlene A Forastiere3, June Corry4, Jonathan J Beitler5, Primož Strojan6, Dana M Hartl7,8, Juan P Rodrigo9,10, Carol R Bradford11, Alessandra Rinaldo12, Robert P Takes13, William M Mendenhall14, Ashok R Shaha15, Gregory T Wolf11, Alfio Ferlito16.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24525999     DOI： 10.1007/s00405-014-2894-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  40 in total

1.  Head and neck squamous cell carcinomas in HIV-positive patients: a preliminary investigation of viral associations.

Authors:  Michael S McLemore; Missak Haigentz; Richard V Smith; Gerard J Nuovo; Llucia Alos; Antonio Cardesa; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2010-03-24

Review 2.  Including persons with HIV infection in cancer clinical trials.

Authors:  Govind C Persad; Richard F Little; Christine Grady
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544

3.  Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.

Authors:  Kevin S Choe; Daniel J Haraf; Abhishek Solanki; Ezra E W Cohen; Tanguy Y Seiwert; Kerstin M Stenson; Elizabeth A Blair; Louis Portugal; Victoria M Villaflor; Mary Ellyn Witt; Everett E Vokes; Joseph K Salama
Journal:  Cancer       Date:  2011-06-13       Impact factor: 6.860

4.  The future of induction chemotherapy for head and neck squamous cell carcinoma.

Authors:  Missak Haigentz; Ezra E W Cohen; Gregory T Wolf; Primož Strojan; Avraham Eisbruch; Alfio Ferlito
Journal:  Oral Oncol       Date:  2012-09-14       Impact factor: 5.337

5.  Primary radiation therapy for head-and-neck cancer in the setting of human immunodeficiency virus.

Authors:  Emily A Klein; Michael Guiou; D Gregory Farwell; Quang Luu; Derick H Lau; Kerri Stuart; Andrew Vaughan; Srinivasan Vijayakumar; Allen M Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-10       Impact factor: 7.038

6.  Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma.

Authors:  Paul M Spring; Joseph Valentino; Susanne M Arnold; David Sloan; Daniel Kenady; Mahesh Kudrimoti; Richard C Haydon; Charles Lee; Curtis Given; Mohammed Mohiuddin; William F Regine
Journal:  Cancer       Date:  2005-10-15       Impact factor: 6.860

7.  Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.

Authors:  Robert Haddad; Anne O'Neill; Guilherme Rabinowits; Roy Tishler; Fadlo Khuri; Douglas Adkins; Joseph Clark; Nicholas Sarlis; Jochen Lorch; Jonathan J Beitler; Sewanti Limaye; Sarah Riley; Marshall Posner
Journal:  Lancet Oncol       Date:  2013-02-13       Impact factor: 41.316

8.  Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615.

Authors:  K Thomas Robbins; Parvesh Kumar; Jonathan Harris; Timothy McCulloch; Anthony Cmelak; Robert Sofferman; Paul Levine; Robert Weisman; William Wilson; Ernest Weymuller; Karen Fu
Journal:  J Clin Oncol       Date:  2005-03-01       Impact factor: 44.544

9.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

10.  Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx.

Authors:  F Christopher Holsinger; Heather Y Lin; Vincent Bassot; Ollivier Laccourreye
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860
View more
  1 in total

1.  Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.

Authors:  Gregory T Wolf; Emily Bellile; Avraham Eisbruch; Susan Urba; Carol R Bradford; Lisa Peterson; Mark E Prince; Theodoros N Teknos; Douglas B Chepeha; Norman D Hogikyan; Scott A McLean; Jeffery Moyer; Jeremy M G Taylor; Francis P Worden
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-04-01       Impact factor: 6.223
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.